查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球实体瘤检测市场规模研究与预测，按类型、按应用、按终端用途和区域分析
市场调查报告书
商品编码
1290515

2023-2030年全球实体瘤检测市场规模研究与预测，按类型、按应用、按终端用途和区域分析

Global Solid Tumor Testing Market Size study & Forecast, by Type, by Application, by End Use and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2022年全球实体瘤检测市场价值约为254.7亿美元，预计在2023-2030年预测期内将以超过7.0%的健康增长率增长。固体肿瘤的特点是不包括液体或囊肿的不受控制的细胞发展。对于肿瘤的早期诊断，实体瘤检测被使用。尽管对实体瘤的生物学进行了大量研究，并开发了检测实体瘤的测试方法，但它们仍然是死亡的主要原因之一。基因检测和常规检测是用于诊断实体瘤的两种方法。由于癌症患病率上升和卵巢癌、胰腺癌和前列腺癌的新产品获批等因素，实体肿瘤检测市场正在扩大。

根据国际癌症研究机构（IARC）的估计，到2040年，全球癌症负担预计将从2021年的190万新病例达到2750万新病例。此外，政府对癌症认识的不断提高，以及发达的医疗基础设施的存在，都在为市场创造有利的增长。此外，实体瘤检测市场的发展还受到技术改进、若干产品的推出以及主要竞争对手的收购、合作和协议策略的推动。例如，罗氏公司在2021年8月宣布，VENTANA MMR RxDx Panel获得了美国食品和药物管理局（FDA）的批准，推进了该公司通过测试识别哪些患者最有可能从特定和目标疗法中受益的个性化医疗承诺。VENTANA MMR RxDx Panel是第一个帮助识别实体瘤在DNA错配修复（dMMR）方面有缺陷的患者的辅助诊断测试。然而，在2023-2030年的预测期内，实体瘤检测的高成本抑制了市场增长。

全球实体瘤检测市场研究的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于重要市场参与者的普遍存在和该地区疾病频率的增加，北美在收入方面主导了市场。另一方面，由于各种因素，如目标人口和老年人口的增加，产品开发合作的数量增加，主要参与者的地理扩张，以及非营利组织和政府组织对市场的积极参与，预计亚太地区在预测期内的年复合增长率最高。

本报告中包括的主要市场参与者有：

  • 齐根公司
  • 奎斯特诊断公司
  • 阿博特实验室
  • 安捷伦科技公司
  • Biocare Medical LLC
  • F.霍夫曼-罗氏公司
  • Illumina, Inc.
  • MedGenome Labs Private Ltd
  • Myriad Genetics, Inc.
  • 赛默飞世尔科技公司

市场的最新发展：

  • 2022年12月，领先的生物技术公司DragonFly Therapeutics, Inc.报告说，HER2靶向TriNKET在晚期实体瘤患者中的2期研究已经给第一个病人用药。
  • 2022年11月，CatalYm c宣布，它筹集了5477万美元，以促进其实体瘤试验和开发新的测试。

全球实体瘤检测市场报告范围：

  • 历史数据：2020 - 2021
  • 估计的基准年：2022年
  • 预测期：2023-2030年
  • 报告覆盖面：收入预测，公司排名，竞争格局，增长因素，和趋势
  • 覆盖的细分市场：类型、应用、终端使用地区
  • 区域范围：北美; 欧洲; 亚太地区; 拉丁美洲; 中东和非洲
  • 定制范围：购买后可免费定制报告（相当于8个分析员的工作时间）。增加或改变国家、区域和部门范围*。
  • 本研究的目的是确定近年来不同细分市场和国家的市场规模，并对未来几年的价值进行预测。该报告旨在将研究涉及的国家内的行业的质量和数量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，并详细分析了竞争格局和主要参与者的产品。.

目录

第一章：执行摘要

  • 市场简介
  • 2020-2030年全球及细分市场的估计和预测
    • 2020-2030年，按地区分類的实体瘤检测市场
    • 2020-2030年，按类型分類的实体瘤检测市场
    • 2020-2030年，按应用分類的实体瘤检测市场
    • 2020-2030年，按终端用途分類的实体瘤检测市场
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球实体瘤检测市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 行业演变
    • 研究的范围
  • 研究考虑的年份
  • 货币兑换率

第三章：全球实体瘤检测市场动态

  • 固体肿瘤检测市场影响分析（2020-2030年）
    • 市场驱动力
      • 癌症的发病率不断提高
      • 卵巢癌、胰腺癌和前列腺癌的新产品获批。
    • 市场挑战
      • 实体肿瘤检测的高成本
    • 市场机会
      • 政府为提高癌症意识而采取的措施越来越多
      • 个性化治疗的不断发展
      • 发达的医疗基础设施的存在

第四章：全球实体瘤检测市场行业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力影响分析
  • PEST分析
    • 政治
    • 经济
    • 社会
    • 技术
    • 环境
    • 法律问题
  • 最佳投资机会
  • 最佳策略
  • COVID-19影响分析
  • 颠覆性趋势
  • 行业专家的观点
  • 分析师建议与结论

第五章：全球实体瘤检测市场，按类型划分

  • 市场简介
  • 按类型分類的全球实体瘤检测市场，性能-潜力分析
  • 2020-2030年全球实体瘤检测市场按类型的估计和预测
  • 固体肿瘤检测市场，細項分析
    • 基因测试
    • 常规测试

第6章：全球实体瘤检测市场，按应用分类

  • 市场简介
  • 全球实体瘤检测市场，按应用，性能-潜力分析
  • 2020-2030年全球实体瘤检测市场按应用估计和预测的情况
  • 固体肿瘤检测市场，細項分析
    • 前列腺
    • 乳腺
    • 大肠杆菌
    • 子宫内膜
    • 肺癌
    • 黑色素瘤
    • 脑癌
    • 其他

第7章 ：全球实体瘤检测市场，按最终用途划分

  • 市场简介
  • 全球实体瘤检测市场，按终端用途，性能-潜力分析
  • 2020-2030年全球实体瘤检测市场按终端用途的估计和预测
  • 固体肿瘤检测市场，次级细分市场分析
    • 医院
    • 制药和生物技术公司
    • 合同研究组织
    • 学术研究机构

第八章：全球实体瘤检测市场，区域分析

  • 最领先的国家
  • 新兴国家
  • 固体肿瘤检测市场，区域市场简介
  • 北美洲
    • 美国
      • 2020-2030年类型细分的估计和预测
      • 2020-2030年，应用细分的估计和预测
      • 2020-2030年终端用途分类估计和预测
    • 加拿大
  • 欧洲实体瘤检测市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区实体瘤检测市场概况
    • 中国
    • 中国
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲实体瘤检测市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第九章：竞争情报

  • 主要公司SWOT分析
    • 公司1
    • 公司二
    • 公司三
  • 顶级市场战略
  • 公司简介
    • Qiagen
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • Quest Diagnostics Inc
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Biocare Medical LLC
    • F. Hoffmann-La Roche AG
    • Illumina, Inc.
    • MedGenome Labs Private Ltd
    • Myriad Genetics, Inc.
    • Thermo Fisher Scientific, Inc

第十章 ：研究过程

  • 研究过程
    • 资料探勘
    • 数据分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Solid Tumor Testing Market is valued at approximately USD 25.47 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2023-2030. A solid tumour is characterized as an uncontrolled cell development that does not include fluids or cysts. For the early-stage diagnosis of tumors, solid tumour testing is used. Despite significant research into the biology of solid tumors and the development of tests for the detection of solid tumors, they remain one of the main causes of death. Genetic and conventional testing are the two methods used to diagnose solid tumors. The Solid Tumor Testing market is expanding because of factors such as the rising prevalence of cancer and new product approvals in ovarian, pancreatic, and prostate cancers.

The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), it is estimated worldwide burden of cancer is projected to reach 27.5 million new cases by 2040 from 1.9 million new cases in the year 2021. In addition, Increasing Government Initiatives for Cancer Awareness, and the presence of developed healthcare infrastructure are creating lucrative growth in the market. Moreover, the development of the solid tumour testing market is also fueled by technical improvements, the introduction of several products, and key competitors' acquisition, partnership, and agreement tactics. For instance, Roche announced in August 2021 that the VENTANA MMR RxDx Panel has received approval from the U.S. Food and Drug Administration (FDA), advancing the company's commitment to personalized healthcare through tests that identify which patients are most likely to benefit from particular and targeted therapies. The first companion diagnostic test to help with patient identification whose solid tumors are defective in DNA mismatch repair (dMMR) is the VENTANA MMR RxDx Panel. However, the high cost of Solid Tumor Testing stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Solid Tumor Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue due to the prevalence of important market players and the increased frequency of diseases in the area. On the other hand, the Asia Pacific region is projected to have the highest CAGR during the forecast period due to a variety of factors, such as an increase in the target and geriatric populations, an increase in the number of product development collaborations, the geographic expansion of major players, and active participation by nonprofit and governmental organisations in the market..

Major market player included in this report are:

  • Qiagen
  • Quest Diagnostics Inc
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Biocare Medical LLC
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • MedGenome Labs Private Ltd
  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific, Inc

Recent Developments in the Market:

  • In December 2022, Leading biotechnology firm DragonFly Therapeutics, Inc. reported that the Phase-2 research of HER2 targeting TriNKET in patients with advanced solid tumors had dosed its first patient.
  • In November 2022, CatalYm c announced it raised USD 54.77 million to boost its solid tumor trials and develop new testing.

Global Solid Tumor Testing Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Application, End Use Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East& Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
  • The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Genetic Testing
  • Conventional Testing

By Application:

  • Prostate
  • Breast
  • Colorectal
  • Endometrial
  • Lung
  • Melanoma
  • Brain
  • Others

By End Use:

  • Hospitals
  • Pharmaceutical and biotechnology companies
  • Contract research organizations
  • Academic research institutions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Solid Tumor Testing Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Solid Tumor Testing Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Solid Tumor Testing Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Solid Tumor Testing Market, by End Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Solid Tumor Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Solid Tumor Testing Market Dynamics

  • 3.1. Solid Tumor Testing Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of cancer
      • 3.1.1.2. New product approvals in ovarian, pancreatic, and prostate cancers.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Solid Tumor Testing
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing Government Initiatives for Cancer Awareness
      • 3.1.3.2. Rising development of personalised treatment
      • 3.1.3.3. Presence of developed healthcare infrastructure

Chapter 4. Global Solid Tumor Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Solid Tumor Testing Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Solid Tumor Testing Market by Type, Performance - Potential Analysis
  • 5.3. Global Solid Tumor Testing Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Solid Tumor Testing Market, Sub Segment Analysis
    • 5.4.1. Genetic Testing
    • 5.4.2. Conventional Testing

Chapter 6. Global Solid Tumor Testing Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Solid Tumor Testing Market by Application, Performance - Potential Analysis
  • 6.3. Global Solid Tumor Testing Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Solid Tumor Testing Market, Sub Segment Analysis
    • 6.4.1. Prostate
    • 6.4.2. Breast
    • 6.4.3. Colorectal
    • 6.4.4. Endometrial
    • 6.4.5. Lung
    • 6.4.6. Melanoma
    • 6.4.7. Brain
    • 6.4.8. Others

Chapter 7. Global Solid Tumor Testing Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Solid Tumor Testing Market by End Use, Performance - Potential Analysis
  • 7.3. Global Solid Tumor Testing Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
  • 7.4. Solid Tumor Testing Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Pharmaceutical and biotechnology companies
    • 7.4.3. Contract research organizations
    • 7.4.4. Academic research institutions

Chapter 8. Global Solid Tumor Testing Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Solid Tumor Testing Market, Regional Market Snapshot
  • 8.4. North America Solid Tumor Testing Market
    • 8.4.1. U.S. Solid Tumor Testing Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Solid Tumor Testing Market
  • 8.5. Europe Solid Tumor Testing Market Snapshot
    • 8.5.1. U.K. Solid Tumor Testing Market
    • 8.5.2. Germany Solid Tumor Testing Market
    • 8.5.3. France Solid Tumor Testing Market
    • 8.5.4. Spain Solid Tumor Testing Market
    • 8.5.5. Italy Solid Tumor Testing Market
    • 8.5.6. Rest of Europe Solid Tumor Testing Market
  • 8.6. Asia-Pacific Solid Tumor Testing Market Snapshot
    • 8.6.1. China Solid Tumor Testing Market
    • 8.6.2. India Solid Tumor Testing Market
    • 8.6.3. Japan Solid Tumor Testing Market
    • 8.6.4. Australia Solid Tumor Testing Market
    • 8.6.5. South Korea Solid Tumor Testing Market
    • 8.6.6. Rest of Asia Pacific Solid Tumor Testing Market
  • 8.7. Latin America Solid Tumor Testing Market Snapshot
    • 8.7.1. Brazil Solid Tumor Testing Market
    • 8.7.2. Mexico Solid Tumor Testing Market
  • 8.8. Rest of The World Solid Tumor Testing Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Qiagen
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Quest Diagnostics Inc
    • 9.3.3. Abbott Laboratories
    • 9.3.4. Agilent Technologies Inc.
    • 9.3.5. Biocare Medical LLC
    • 9.3.6. F. Hoffmann-La Roche AG
    • 9.3.7. Illumina, Inc.
    • 9.3.8. MedGenome Labs Private Ltd
    • 9.3.9. Myriad Genetics, Inc.
    • 9.3.10. Thermo Fisher Scientific, Inc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Solid Tumor Testing Market, report scope
  • TABLE 2. Global Solid Tumor Testing Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Solid Tumor Testing Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Solid Tumor Testing Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Solid Tumor Testing Market estimates & forecasts by End Use 2020-2030 (USD Billion)
  • TABLE 6. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Solid Tumor Testing Market
  • TABLE 71. List of primary sources, used in the study of global Solid Tumor Testing Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Solid Tumor Testing Market, research methodology
  • FIG 2. Global Solid Tumor Testing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Solid Tumor Testing Market, key trends 2022
  • FIG 5. Global Solid Tumor Testing Market, growth prospects 2023-2030
  • FIG 6. Global Solid Tumor Testing Market, porters 5 force model
  • FIG 7. Global Solid Tumor Testing Market, pest analysis
  • FIG 8. Global Solid Tumor Testing Market, value chain analysis
  • FIG 9. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Solid Tumor Testing Market, regional snapshot 2020 & 2030
  • FIG 15. North America Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Solid Tumor Testing Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable